These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Retracted: The AKT/mTOR Signaling Pathway was Mediated through the LINC00514/miR-28-5p/TRIM44 Axis. Markers D Dis Markers; 2023; 2023():9794271. PubMed ID: 38077932 [TBL] [Abstract][Full Text] [Related]
24. Retracted: DDTC Suppresses Ovarian Cancer Development via the PI3K/AKT/mTOR Signaling Pathway. Markers D Dis Markers; 2023; 2023():9810565. PubMed ID: 37502573 [TBL] [Abstract][Full Text] [Related]
25. Retracted: Oleuropein Improves Cognitive Dysfunction and Neuroinflammation in Diabetic Rats through the PI3K/Akt/mTOR Pathway. And Biomechanics AB Appl Bionics Biomech; 2023; 2023():9813730. PubMed ID: 38075082 [TBL] [Abstract][Full Text] [Related]
26. [Retracted] Rapamycin suppresses the PI3K/AKT/mTOR signaling pathway by targeting SIRT1 in esophageal cancer. Liu T; Liang X; Sun Y; Yang S Exp Ther Med; 2024 Jan; 27(1):1. PubMed ID: 38125358 [TBL] [Abstract][Full Text] [Related]
27. CD73/NT5E is a target of miR-30a-5p and plays an important role in the pathogenesis of non-small cell lung cancer. Zhu J; Zeng Y; Li W; Qin H; Lei Z; Shen D; Gu D; Huang JA; Liu Z Mol Cancer; 2017 Feb; 16(1):34. PubMed ID: 28158983 [TBL] [Abstract][Full Text] [Related]
28. Lamin B1 Overexpresses in Lung Adenocarcinoma and Promotes Proliferation in Lung Cancer Cells via AKT Pathway [Retraction]. Onco Targets Ther; 2023; 16():747-748. PubMed ID: 37719640 [TBL] [Abstract][Full Text] [Related]
29. Critical and diverse involvement of Akt/mammalian target of rapamycin signaling in human lung carcinomas. Dobashi Y; Suzuki S; Matsubara H; Kimura M; Endo S; Ooi A Cancer; 2009 Jan; 115(1):107-18. PubMed ID: 19090006 [TBL] [Abstract][Full Text] [Related]
30. MicroRNA-30a suppresses self-renewal and tumorigenicity of glioma stem cells by blocking the NT5E-dependent Akt signaling pathway. Peng L; Ming Y; Zhang L; Zhou J; Xiang W; Zeng S; He H; Chen L FASEB J; 2020 Apr; 34(4):5128-5143. PubMed ID: 32067282 [TBL] [Abstract][Full Text] [Related]
31. Retracted: miR-138 Reduces the Dysfunction of T Follicular Helper Cells in Osteosarcoma via the PI3K/Akt/mTOR Pathway by Targeting PDK1. Methods In Medicine CAM Comput Math Methods Med; 2023; 2023():9765985. PubMed ID: 37799431 [TBL] [Abstract][Full Text] [Related]
32. Retracted: LINC00092 Modulates Oxidative Stress and Glycolysis of Breast Cancer Cells via Pyruvate Carboxylase-Mediated AKT/mTOR Pathway. Longevity OMAC Oxid Med Cell Longev; 2023; 2023():9864513. PubMed ID: 38189021 [TBL] [Abstract][Full Text] [Related]
33. Retracted: Senkyunolide H Affects Cerebral Ischemic Injury through Regulation on Autophagy of Neuronal Cells Via P13K/AKT/mTOR Signaling Pathway. Markers D Dis Markers; 2023; 2023():9861720. PubMed ID: 37387771 [TBL] [Abstract][Full Text] [Related]
34. mRNA expression of programmed cell death ligand 1 and components of the phosphatidylinositol 3-kinase/AKT/phosphatase and tensin homolog pathway in epidermal growth factor receptor mutation-positive lung adenocarcinoma. Han K; Zhang Y J Cancer Res Ther; 2019; 15(4):914-920. PubMed ID: 31436252 [TBL] [Abstract][Full Text] [Related]
35. TAZ inhibition restores sensitivity of cisplatin via AKT/mTOR signaling in lung adenocarcinoma. Xu W; Wei Y; Li Y; Yin Y; Yuan W; Yang Y; Zhao W; Wu J Oncol Rep; 2017 Sep; 38(3):1815-1821. PubMed ID: 28737828 [TBL] [Abstract][Full Text] [Related]
36. Retracted: TMEM60 Promotes the Proliferation and Migration and Inhibits the Apoptosis of Glioma through Modulating AKT Signaling. Oncology JO J Oncol; 2023; 2023():9767535. PubMed ID: 36727156 [TBL] [Abstract][Full Text] [Related]
37. Retracted: Knockdown of miR-372-3p Inhibits the Development of Diabetic Cardiomyopathy by Accelerating Angiogenesis via Activating the PI3K/AKT/mTOR/HIF-1 Longevity OMAC Oxid Med Cell Longev; 2023; 2023():9819824. PubMed ID: 37388518 [TBL] [Abstract][Full Text] [Related]
38. Retracted: CircNR3C1 Alleviates Gastric Cancer Development by Inactivating AKT/mTOR. Healthcare Engineering JO J Healthc Eng; 2023; 2023():9828679. PubMed ID: 37829407 [TBL] [Abstract][Full Text] [Related]
39. Retracted: LINC01426 Triggers Growth and Metastasis of Lung Adenocarcinoma as a Prognostic Indicator. International BR Biomed Res Int; 2023; 2023():9890620. PubMed ID: 38075342 [TBL] [Abstract][Full Text] [Related]
40. Retracted: Curcumin Inhibits the Proliferation of Renal Cancer 786-O Cells through MTOR Signaling Pathway and Its Mechanism. Healthcare Engineering JO J Healthc Eng; 2023; 2023():9784315. PubMed ID: 37476781 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]